| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8945692 | American Journal of Otolaryngology | 2018 | 6 Pages |
Abstract
Our fractionation regimen provides tumor control consistent with current literature. Hearing outcomes, however, should be discussed with patients prior to CyberKnife stereotactic radiotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
James A. Gallogly, Mejd Jumaily, Farhoud Faraji, Anthony A. Mikulec,